Lupin enters into BTA with Lupin Life Sciences

10 Jun 2024 Evaluate

Lupin has entered into Business Transfer Agreement (BTA) with Lupin Life Sciences (LLSL) wholly owned subsidiary of the Company, to carve out, its trade generics business in India, as a going concern, on a slump sale basis. The said carve out will be effective from July 1, 2024.  

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2178.20 1.95 (0.09%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×